Eli Somer
Oct 31, 20191 min
This new study report by Drs. Colin Ross, Melina West and Eli Somer presents data from 202 individuals who were assessed as likely to suffer from maladaptive daydreaming (MD). Their overall conclusion was that no strong recommendations should be made in favor of any type of medication for individuals with MD at this time and until more definitive studies have been conducted. Comorbid disorders should be treated with an available evidence-based medication or psychotherapy. However, it appears that tentative recommendations can be made in favor of prescribing antidepressants, particularly SSRIs, and against the use of marijuana for individuals with MD. It seems that psychotherapy is a more effective treatment for MD than medications; we recommend that future research investigate this possibility using a therapy protocol specific for MD.